Hamartoma Syndrome, Multiple: Clinical Trials

26 trials for Hamartoma Syndrome, Multiple, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 8 recruiting, 3 active not recruiting, 2 unknown. 7 Phase 2, 5 Phase 1, 4 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 15Completed 4, Withdrawn 1
Not applicable4Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1
Phase 31Not yet recruiting 1

Follow Hamartoma Syndrome, Multiple: new trials by email Literature Review of Hamartoma Syndrome, Multiple trials Research Report on Hamartoma Syndrome, Multiple

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations
Everolimus blinded oral capsules, Placebo - Cowden's Disease, Cowden's Syndrome
Phase 2 / Phase 3Not yet recruitingBoston Children's Hospital602026-09-012026-06-04
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
Nipple Sparing Mastectomy (NSM), Skin-Sparing Mastectomy (SSM), Total (Simple) Mastectomy - Breast Cancer Surgery
RecruitingSir Mortimer B. Davis - Jewish General Hospital47002025-02-012026-08-18
Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
PTEN Hamartoma Syndrome
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta502024-08-012026-02-12
Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
Sirolimus, Placebo - PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome
Phase 1 / Phase 2WithdrawnStanford University2024-07-012024-07-10
Video Capsule Examination in Patients With Lynch Syndrome
Video capsule investigation - Lynch Syndrome, Li Fraumeni Syndrome
Not applicableRecruitingRoyal Marsden NHS Foundation Trust252024-03-042024-12-05
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
Functional Behavioral Training (FBT), Positive Parenting Strategies-Treatment as Usual - Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis
Not applicableActive not recruitingRush University Medical Center792023-09-152026-09-18
PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
PTEN Hamartoma Tumor Syndrome, Macrocephaly Autism Syndrome
RecruitingYale University1002022-11-012026-08-31
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract
RecruitingUniversidad Nacional Autonoma de Mexico7502022-08-032024-07-26
Inherited Cancer Early Diagnosis (ICED) Study
Li Fraumeni Syndrome, Lynch Syndrome
UnknownRoyal Marsden NHS Foundation Trust1002022-07-262023-12-08
MK-7075 (Miransertib) in Proteus Syndrome
MK-7075 (miransertib) - Proteus Syndrome
Phase 2Active not recruitingNational Human Genome Research Institute (NHGRI)382022-05-202026-07-17
Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
NET - PTEN Hamartoma Tumor Syndrome
CompletedJohn Carroll University3002021-09-092024-09-19
Sirolimus for Cowden Syndrome With Colon Polyposis
Sirolimus - PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome
Phase 2CompletedOhio State University52019-09-162025-06-10
Response of Immune System to Flu Vaccination in PHTS
Influvac Tetra - PTEN Hamartoma Tumor Syndrome
Not applicableUnknownRadboud University Medical Center302018-10-012018-08-15
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Cancer, Breast Cancer
RecruitingUniversity Health Network, Toronto25002017-08-032026-09-25
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
RAD001, Placebo - PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome
Phase 1 / Phase 2CompletedBoston Children's Hospital462017-06-122025-02-17
Familial Investigations of Childhood Cancer Predisposition
Acute Leukemia, Adenomatous Polyposis
RecruitingSt. Jude Children's Research Hospital15002017-04-062026-06-17
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
MK-7075 (miransertib) - Proteus Syndrome
Phase 1CompletedNational Human Genome Research Institute (NHGRI)62015-11-162022-06-30
DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
dermal electrochemical conductance (DEC), Monofilament testing - Neuropathy, Diabetic, Diabetes Mellitus, Type 2
Not applicableCompletedFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1472015-05-012019-02-27
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
PTEN, ASD
Active not recruitingBoston Children's Hospital1802015-05-012026-08-06
Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Coronary Artery Disease, Proteus Syndrome
CompletedNational Human Genome Research Institute (NHGRI)302011-05-292018-07-26

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Li-Fraumeni Syndrome (6)  ·  Autistic Disorder (5)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (5)  ·  Proteus Syndrome (5)  ·  Breast Neoplasms (4)  ·  Peutz-Jeghers Syndrome (3)  ·  Tuberous Sclerosis (3)  ·  Adenomatous Polyposis Coli (2)  ·  Carney Complex (2)  ·  Growth Disorders (2)  ·  Hereditary Sensory and Autonomic Neuropathies (2)  ·  Megalencephaly (2)  ·  Melanoma (2)  ·  Multiple Endocrine Neoplasia Type 1 (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (26)  ·  Hamartoma (26)  ·  Neoplasms, Multiple Primary (26)  ·  Neoplasms (24)  ·  Genetic Diseases, Inborn (22)  ·  Neoplastic Syndromes, Hereditary (21)  ·  Congenital Abnormalities (10)  ·  Nervous System Diseases (10)  ·  Metabolic Diseases (8)  ·  Musculoskeletal Abnormalities (8)  ·  Musculoskeletal Diseases (8)  ·  Neoplasms by Site (8)  ·  Nutritional and Metabolic Diseases (8)  ·  Abnormalities, Multiple (7)  ·  DNA Repair-Deficiency Disorders (7)

Interventions

Miransertib (3)  ·  Sirolimus (3)  ·  Everolimus (2)  ·  8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-piperazin-1-yl-3-trifluoromethylphenyl)-1,3-dihydroimidazo(4,5-c)quinolin-2-one (1)  ·  Colonoscopy (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Mastectomy (1)  ·  Mastectomy, Subcutaneous (1)  ·  Physical Examination (1)  ·  dactolisib (1)

Sponsors

National Human Genome Research Institute (NHGRI) (4)  ·  Boston Children's Hospital (3)  ·  National Cancer Institute (NCI) (2)  ·  Novartis Pharmaceuticals (2)  ·  Royal Marsden NHS Foundation Trust (2)  ·  ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) (1)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  John Carroll University (1)  ·  Ohio State University (1)  ·  Radboud University Medical Center (1)  ·  Rush University Medical Center (1)  ·  Sir Mortimer B. Davis - Jewish General Hospital (1)  ·  St. Jude Children's Research Hospital (1)  ·  Stanford University (1)

Countries

United States (17)  ·  United Kingdom (5)  ·  Canada (3)  ·  Spain (3)  ·  Australia (1)  ·  Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Leslie G Biesecker, M.D. (3)  ·  Antonio Hardan, MD (2)  ·  Angela George (1)  ·  Arun Rajan, M.D. (1)  ·  Barbara B Biesecker (1)  ·  Bernardo Costa, MD (1)  ·  Hande Kaymakcalan Celebiler, MD (1)  ·  Kim E. Nichols, MD (1)  ·  Lillian Siu, MD (1)  ·  Mustafa Sahin, MD, PhD (1)  ·  Peter P Stanich, MD (1)  ·  Richard Lee, PhD (1)  ·  Sharon A Savage, M.D. (1)

Results publications

PMID 34649967, PMID 20458532, PMID 23344409, PMID 30803705, PMID 31350329, PMID 33509259, PMID 35594551, PMID 35705312, PMID 35839129, PMID 36670100, PMID 37027812, PMID 37972346, PMID 40478255, PMID 40632977, PMID 42224880, PMID 42289769

NIH funding

U54NS092090 (2)